Uniting key ALS and FTD stakeholders across pharma, biotech, academia, patient and caregiver communities, key research funding organizations and advocacy groups, the 4^th ALS Drug Development Summit was the ultimate platform honing industry R&D for safer, more effect and patient-relevant drugs that serve the community, driving a cure for sporadic and familial ALS.